Skip to main content
Premium Trial:

Request an Annual Quote

Marina Issued Notice of Allowance on Canadian Patent Application for Delivery Tech

Premium

Marina Biotech said this week that the Canadian patent office has issued the company a notice of allowance for a patent application covering amphoteric liposomal formulations and their use for the delivery of nucleic acids and other compounds with therapeutic application.

The application, No. 2,438,116, specifically relates to Marina's Smarticles technology, which it acquired from Novosom last summer (GSN 7/29/2010).

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.